| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Thomas John C serves as a Director at IBRX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 19 sells. Those positions are worth an estimated $2.3M at current prices.
The biggest single holding is IBRX (~$2.2M) as Director. The recent filings there lean toward selling, a net 252,760 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 1,000 | $5.65 | $5,650.00 | New | -17.2% | -95.7% | |
| Dec 10, 2020 | IBRX Immunitybio, Inc. | Director | Sell | 42,592 | $10.83 | $461,122.29 | -17.0% | - | - | |
| Aug 19, 2020 | IBRX Immunitybio, Inc. | Director | Sell | 20,000 | $9.19 | $183,800.00 | -7.4% | - | - | |
| Aug 13, 2020 | IBRX Immunitybio, Inc. | Director | Sell | 60,000 | $9.73 | $583,642.00 | -18.2% | - | - | |
| Dec 16, 2019 | IBRX Immunitybio, Inc. | Director | Sell | 30,000 | $2.87 | $86,000.00 | -8.3% | - | - | |
| Dec 12, 2019 | IBRX Immunitybio, Inc. | Director | Sell | 10,000 | $1.99 | $19,918.00 | -2.7% | - | - | |
| Sep 9, 2019 | IBRX Immunitybio, Inc. | Director | Sell | 24,000 | $1.24 | $29,789.64 | -6.1% | - | - | |
| Jun 20, 2017 | IBRX Immunitybio, Inc. | Director | Sell | 40,000 | $7.46 | $298,500.00 | -12.6% | - | - | |
| Nov 25, 2016 | IBRX Immunitybio, Inc. | Director | Sell | 6,168 | $7.50 | $46,260.00 | -2.0% | - | - | |
| Nov 23, 2016 | IBRX Immunitybio, Inc. | Director | Sell | 20,000 | $7.50 | $150,000.00 | -6.0% | - | - |